VAERS reports by lot

GSK Varicella/Shingles lot 394KF: VAERS reports

32 VAERS reports list lot 394KF as a GSK Varicella/Shingles vaccine, received between 2020-12-18 and 2022-01-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
32
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2525%
General / Systemic (non-local)1818%
Neurological1616%
Musculoskeletal1010%
Dermatological (non-injection-site)1010%
Gastrointestinal99%
Respiratory66%
Cardiac / Cardiovascular33%
Allergic / Anaphylactic33%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan6
Illinois4
Washington3
Maryland2
Wisconsin2
New Hampshire2
Puerto Rico2
Oregon1
Arizona1
Virginia1
Texas1
Idaho1

Reports by month received

2020-126
2021-0110
2021-028
2021-032
2021-041
2021-053
2021-121
2022-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.